Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis ; volume:13 ; number:1 ; day:14 ; month:11 ; year:2013 ; pages:1-14 ; date:12.2013
BMC cardiovascular disorders ; 13, Heft 1 (14.11.2013), 1-14, 12.2013
- Urheber
-
Li-Sha, Ge
- Beteiligte Personen und Organisationen
-
Yi-He, Chen
Na-Dan, Zhou
Teng, Zhang
Yue-Chun, Li
SpringerLink (Online service)
- DOI
-
10.1186/1471-2261-13-100
- URN
-
urn:nbn:de:1111-2016032613964
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li-Sha, Ge
- Yi-He, Chen
- Na-Dan, Zhou
- Teng, Zhang
- Yue-Chun, Li
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of colchicine on experimental Coxsackievirus B3-induced myocarditis
Impact of cardiac stromal cells on Coxsackievirus B3-induced myocarditis
Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
Myocarditis und Cardiomyopathie : Virusnachweis bei der experimentellen Coxsackievirus B3 Myocarditits und deren Folgekrankheit
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Role of NOD2 and S100A8/S100A9 in the pathogenesis of Coxsackievirus B3-induced myocarditis
IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
The whole genome sequence of Coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis
Increased Expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis
Impact of colchicine on experimental Coxsackievirus B3-induced myocarditis
Impact of cardiac stromal cells on Coxsackievirus B3-induced myocarditis
Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
Myocarditis und Cardiomyopathie : Virusnachweis bei der experimentellen Coxsackievirus B3 Myocarditits und deren Folgekrankheit
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Role of NOD2 and S100A8/S100A9 in the pathogenesis of Coxsackievirus B3-induced myocarditis
IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
The whole genome sequence of Coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis
Increased Expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis
Impact of colchicine on experimental Coxsackievirus B3-induced myocarditis
Impact of cardiac stromal cells on Coxsackievirus B3-induced myocarditis
Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
Myocarditis und Cardiomyopathie : Virusnachweis bei der experimentellen Coxsackievirus B3 Myocarditits und deren Folgekrankheit
Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance
Role of NOD2 and S100A8/S100A9 in the pathogenesis of Coxsackievirus B3-induced myocarditis
IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis
Identifizierung neutralisierender Antigendeterminanten von Coxsackievirus B3 und Coxsackievirus B4
CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
The whole genome sequence of Coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis